SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-041377
Filing Date
2017-08-09
Accepted
2017-08-09 06:11:52
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v471765_10q.htm 10-Q 366413
2 EXHIBIT 31.1 v471765_ex31-1.htm EX-31.1 11617
3 EXHIBIT 31.2 v471765_ex31-2.htm EX-31.2 11767
4 EXHIBIT 32.1 v471765_ex32-1.htm EX-32.1 4810
  Complete submission text file 0001144204-17-041377.txt   3917584

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20170630.xml EX-101.INS 854534
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20170630.xsd EX-101.SCH 47267
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20170630_cal.xml EX-101.CAL 24982
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20170630_def.xml EX-101.DEF 270330
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20170630_lab.xml EX-101.LAB 358110
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20170630_pre.xml EX-101.PRE 304356
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 171016342
SIC: 2834 Pharmaceutical Preparations